Helium Ventures
plc
(“Helium Ventures” or the
“Company”)
Half-Year Report
for the Six Months Ended 31 October
2024
Helium Ventures plc
(AQSE:HEV), presents its unaudited interim results for the
six-month period ended 31 October
2024.
Chairman’s
Statement
I am pleased to present
the interim financial statements for Helium Ventures Plc for the
six-month period from 1 May 2024 to
31 October 2024.
During the period, the
Company maintained its investment portfolio, which
includes:
-
Vestigo Technologies
Ltd ("Trackimo" or "Vestigo")
On 9 October 2023, the Company entered into an
agreement to subscribe for £250,000 in new ordinary shares of
Trackimo, funded through the proceeds of a placing. As announced
6 June 2024, the Company was issued
1,032,407 ordinary A class shares at a price of approximately £1.84
per share in Trackimo representing a 19.36% equity stake at the
time, as determined by an independent valuation which was triggered
by the expiry of the long stop date for Trackimo completing an IPO.
The ordinary A class shares the Company was issued is inclusive of
the £250,000 subscription the Company made in
Trackimo. Trackimo continues to
trade in line with expectations.
-
Blue Star Helium
Limited
The Company holds
7,142,858 ordinary shares in Blue Star Helium Limited, an
ASX-listed company with significant helium exploration acreage in
the USA. In recent months, Blue
Star announced the mobilisation of a drilling rig to the
Jackson 31 site within the
Galactica Project in Las Animas County,
Colorado, as part of a five-well programme. Initial results
from this drilling campaign are expected in H1
2025.
Looking ahead, the Board
remains focused on identifying and evaluating strategic
opportunities to enhance shareholder value, following the
termination of the Trackimo RTO. This work is ongoing, and we will
keep shareholders informed as we progress.
The Company continues to
carefully manage its working capital position and may need to raise
further capital in the future through equity or alternative
financing agreements. There can be no guarantee that funding
discussions will result in new funding being secured nor that that
the terms of any such agreement will be favourable to the Company
and its shareholders. Further announcements will be made in due
course.
On behalf of the Board, I
would like to extend my gratitude to our shareholders, fellow
directors, and professional advisers for their continued
support.
Neil Ritson
Chairman
30 January 2025
The Directors of the
Company accept responsibility for the contents of this
announcement. This announcement contains inside information for the
purposes of UK Market Abuse Regulation.
Enquiries:
Helium Ventures
plc
Neil
Ritson
|
+44 (0) 20 3475
6834
|
Cairn Financial Advisers
LLP (AQSE Corporate Adviser)
Liam Murray / Ludovico
Lazzaretti
|
+44 (0) 20 72130
880
|
For
more information please visit: www.heliumvs.com
Note:
Certain statements made in
this announcement are forward-looking statements. These
forward-looking statements are not historical facts but rather are
based on the Company's current expectations, estimates, and
projections about its industry; its beliefs; and assumptions. Words
such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,'
'seeks,' 'estimates,' and similar expressions are intended to
identify forward-looking statements. These statements are not a
guarantee of future performance and are subject to known and
unknown risks, uncertainties, and other factors, some of which are
beyond the Company's control, are difficult to predict, and could
cause actual results to differ materially from those expressed or
forecasted in the forward-looking statements. The Company cautions
security holders and prospective security holders not to place
undue reliance on these forward-looking statements, which reflect
the view of the Company only as of the date of this announcement.
The forward-looking statements made in this announcement relate
only to events as of the date on which the statements are made. The
Company will not undertake any obligation to release publicly any
revisions or updates to these forward-looking statements to reflect
events, circumstances, or unanticipated events occurring after the
date of this announcement except as required by law or by any
appropriate regulatory authority.
HELIUM VENTURES
PLC – CONDENSED INTERIM FINANCIAL
STATEMENTS
STATEMENT OF
COMPREHENSIVE INCOME
FOR THE PERIOD
FROM 1 MAY 2024 TO 31 OCTOBER 2024
|
|
Unaudited
Period ended 31
October 2024
|
Unaudited
Period ended 31
October 2023
|
Audited
Year
ended 30 April
2024
|
|
Notes
|
£
|
£
|
£
|
|
|
|
|
|
Administrative
expenses
|
|
(65,121)
|
(44,373)
|
(291,175)
|
Fair value through profit
& loss
|
7
|
(16,027)
|
(42,103)
|
(86,920)
|
Other
income
|
|
-
|
-
|
86,431
|
Operating
loss
|
|
(81,148)
|
(86,476)
|
(291,664)
|
Foreign exchanges
losses
|
|
-
|
-
|
(396)
|
Finance
income/(expense)
|
|
-
|
-
|
-
|
Loss before
taxation
|
|
(81,148)
|
(86,476)
|
(292,060)
|
Income
tax
|
|
-
|
-
|
-
|
Loss for the
period from continuing operations
|
|
(81,148)
|
(86,476)
|
(292,060)
|
Total loss for the
year attributable to equity holders of the
Company
|
|
|
|
|
Other comprehensive
loss
|
|
-
|
-
|
-
|
Total
comprehensive loss attributable to equity holders of the
Company
|
|
(81,148)
|
(86,476)
|
(292,060)
|
|
|
|
|
|
|
|
|
|
|
Basic & dilutive
earnings per ordinary share (pence)
|
6
|
(0.34)
|
(0.48)
|
(1.38)
|
|
|
|
|
|
The notes form an integral
part of the Unaudited Condensed Interim Financial
Statements.
HELIUM VENTURES
PLC – CONDENSED INTERIM FINANCIAL
STATEMENTS
STATEMENT OF
FINANCIAL POSITION
AS AT 31 OCTOBER
2024
|
Note
|
Unaudited
As at 31 October
2024
£
|
Unaudited
As at 31 October
2023
£
|
Audited
As at 30
April
2024
£
|
NON-CURRENT
ASSETS
|
|
|
|
|
Investments held at fair
value through profit or loss
|
7
|
250,000
|
-
|
250,000
|
|
|
|
|
|
CURRENT
ASSETS
|
|
|
|
|
Cash and cash
equivalents
|
|
36,955
|
116,171
|
56,215
|
Trade and other
receivables
|
|
21,227
|
256,914
|
15,407
|
Investments held at fair
value through profit or loss
|
7
|
13,663
|
74,506
|
29,689
|
TOTAL CURRENT
ASSETS
|
|
71,845
|
447,591
|
101,311
|
TOTAL
ASSETS
|
|
321,845
|
447,591
|
351,311
|
|
|
|
|
|
EQUITY
|
|
|
|
|
Share
capital
|
8
|
239,025
|
239,025
|
239,025
|
Share premium
account
|
8
|
1,004,380
|
1,004,380
|
1,004,380
|
Share based
payment reserve
|
|
18,615
|
18,615
|
18,615
|
Retained
deficit
|
|
(1,319,039)
|
(1,032,307)
|
(1,237,891)
|
TOTAL
EQUITY
|
|
(57,019)
|
229,713
|
24,129
|
|
|
|
|
|
CURRENT
LIABILITIES
|
|
|
|
|
Trade and other
payables
|
|
378,864
|
217,878
|
327,182
|
TOTAL CURRENT
LIABILITIES
|
|
378,864
|
217,878
|
327,182
|
TOTAL
LIABILITIES
|
|
378,864
|
217,878
|
327,182
|
TOTAL EQUITY AND
LIABILITIES
|
|
321,845
|
447,591
|
351,311
|
The notes form an integral
part of the Unaudited Condensed Interim Financial
Statements.
HELIUM VENTURES
PLC – CONDENSED INTERIM FINANCIAL
STATEMENTS
STATEMENT OF
CASHFLOW
FOR THE 6 MONTH
PERIOD ENDED 31 OCTOBER
2024
|
|
Unaudited
Period
to 31 October 2024
|
Unaudited
Period
to 31 October 2023
|
Audited
Year
ended 30 April
2024
|
|
|
£
|
£
|
£
|
Cash flow from
operating activities
|
|
|
|
|
Loss before income
tax
|
|
(81,148)
|
(86,476)
|
(292,060)
|
Adjustments
for
|
|
|
|
|
Fair value
adjustment
|
|
16,027
|
42,103
|
86,920
|
Share based
payments
|
|
-
|
-
|
15,000
|
Changes in working
capital:
|
|
|
|
|
Decrease / (increase) in
other receivables
|
|
(5,821)
|
(3,917)
|
(12,405)
|
Decrease / (increase) in
other payables
|
|
51,682
|
99,769
|
194,069
|
Net cash (used
in)/ from in operating activities
|
|
(19,260)
|
51,479
|
(8,476)
|
|
|
|
|
|
Cash flows from
investing activities
|
|
|
|
|
Investment in
Trackimo
|
|
-
|
(250,000)
|
(250,000)
|
Net cash flow from
investing activities
|
|
-
|
(250,000)
|
(250,000)
|
|
|
|
|
|
Cashflows from
financing activities
|
|
|
|
|
Proceeds from issue of
ordinary shares
|
|
-
|
250,000
|
250,000
|
Net cash flow from
financing activities
|
|
-
|
250,000
|
250,000
|
|
|
|
|
|
Net increase in
cash and cash equivalents
|
|
(19,260)
|
51,479
|
(8,476)
|
Cash and cash
equivalents at beginning of the period
|
|
56,215
|
64,692
|
64,691
|
Cash and cash
equivalents at end of the period
|
|
36,955
|
116,171
|
56,215
|
The notes form an integral
part of the Unaudited Condensed Interim Financial
Statements.
HELIUM VENTURES
PLC – CONDENSED INTERIM FINANCIAL
STATEMENTS
STATEMENT OF
CHANGES IN EQUITY
FOR THE 6 MONTH
PERIOD TO 31 OCTOBER
2024
|
Ordinary
Share capital
|
Share
Premium
|
Share
Based Payment Reserves
|
Retained
deficit
|
Total
equity
|
|
£
|
£
|
£
|
£
|
£
|
As at 30
April 2023
|
168,400
|
810,005
|
18,615
|
(945,831)
|
51,189
|
Comprehensive
income for the year
|
-
|
-
|
-
|
-
|
-
|
Loss for
the year
|
-
|
-
|
-
|
(292,060)
|
(292,060)
|
Other
comprehensive income
|
-
|
-
|
-
|
-
|
-
|
Total
comprehensive loss for the year
|
-
|
-
|
-
|
(292,060)
|
(292,060)
|
|
|
|
|
|
|
Transactions
with owners
|
|
|
|
|
|
Ordinary
Shares issued
|
70,625
|
211,875
|
-
|
-
|
282,500
|
Warrants
issued
|
-
|
-
|
-
|
-
|
-
|
Share Issue
Costs
|
-
|
(17,500)
|
-
|
-
|
(17,500)
|
Total
transactions with owners
|
70,625
|
194,375
|
-
|
-
|
265,000
|
As
at 30 April 2024
|
239,025
|
1,004,380
|
18,615
|
(1,237,891)
|
24,129
|
|
Ordinary
Share capital
|
Share
Premium
|
Share
Based Payment Reserves
|
Retained
deficit
|
Total
equity
|
|
£
|
£
|
£
|
£
|
£
|
As at 1 May
2024
|
239,025
|
1,004,380
|
18,615
|
(1,237,891)
|
24,129
|
Comprehensive
income for the period
|
|
|
|
|
|
Loss for
the period
|
-
|
-
|
-
|
(81,148)
|
(81,148)
|
Other
comprehensive income
|
-
|
-
|
-
|
-
|
-
|
Total
comprehensive loss for the period
|
-
|
-
|
-
|
(81,148)
|
(81,148)
|
|
|
|
|
|
|
Transactions
with owners
|
|
|
|
|
|
Ordinary
Shares issued
|
-
|
-
|
-
|
-
|
-
|
Warrants
issued
|
-
|
-
|
-
|
-
|
-
|
Share Issue
Costs
|
-
|
-
|
-
|
-
|
-
|
Total
transactions with owners
|
-
|
-
|
-
|
-
|
-
|
As
at 31 October 2024
|
239,025
|
1,004,380
|
18,615
|
(1,319,039)
|
(57,019)
|
The notes form an integral
part of the Unaudited Condensed Interim Financial
Statements.
HELIUM VENTURES
PLC – CONDENSED INTERIM FINANCIAL
STATEMENTS
NOTES TO THE
INTERIM FINANCIAL INFORMATION
FOR THE PERIOD
FROM 1 MAY 2024 TO 31 OCTOBER 2024
1
General
information
The Company was
incorporated on 23 April 2021 in
England and Wales with Registered Number 13355240 under
the Companies Act 2006.
The address of its
registered office is Eccleston Yards, 25 Eccleston Place,
London SW1W 9NF, United Kingdom.
The principal activity of
the Company is to seek suitable investment opportunities in the
technology sector.
The Company commenced
trading on the Aquis Stock Exchange (AQSE) Growth Market on
8 July 2021.
2
Accounting
Policies
IAS 8 requires that
management shall use its judgement in developing and applying
accounting policies that result in information which is relevant to
the economic decision-making needs of users, that are reliable,
free from bias, prudent, complete and represent faithfully the
financial position, financial performance and cash flows of the
entity.
3
Basis of
preparation
The Condensed Interim
Financial Statements have been prepared in accordance with the
requirements of the AQSE Rules and International Accounting
Standards in conformity with the requirements of the Companies Act
2006 and the Companies Act 2006 applicable to companies reporting
under IFRS.
The Condensed Interim
Financial Statements have not been prepared in accordance with IAS
34 “Interim Financial Statements.” The Condensed Interim Financial
Statements do not include all disclosures that would otherwise be
required in a complete set of financial statements but have been
prepared in accordance with the existing accounting policies of the
Company.
The Interim Financial
Statements for the period from 1 May
2024 to 31 October 2024 are
unaudited.
The Company Financial
Information has been prepared using the measurement bases specified
by IFRS for each type of asset, liability, income and
expense.
The Historic Financial
Information does not constitute statutory accounts within the
meaning of section 434 of the Companies Act 2006.
The Historic Financial
Information is presented in £ unless otherwise stated, which is the
Company’s functional and presentational currency.
Going
concern
The Directors have made an
assessment of the Company’s ability to continue as a going concern
and are satisfied that the company has the adequate resources to
continue in operational existence for the foreseeable future. The
Company, therefore, continues to adopt the going concern basis in
preparing its interim financial statements.
Accounting
policies
The same accounting
policies, presentation and methods of computation have been
followed in these Condensed Interim Financial Statements as were
applied in the preparation of the Company’s historic financial
information for the year ended 30 April
2023 except for the impact of the adoption of the Standards
and interpretations described below and new accounting policies
adopted as a result of changes in the Company.
Standards and
interpretations adopted in the period
There were no new
standards or interpretations adopted by the Company in the
period.
New standards and
interpretations not yet adopted
At the date of approval of
these financial statements, the following standards and
interpretations which have not been applied in these financial
statements were in issue but not yet effective (and in some cases
have not yet been adopted by the UK):
Standard
|
Impact on initial
application
|
Effective
date
|
Amendments to IAS
1
|
Classification of
liabilities as Current or Non-current, effective from 1 January
2024
|
1 January
2024
|
Amendments to IFRS 16
Leases
|
Lease Liability in a Sale
and Leasebacks
|
1 January
2024
|
Amendments to IAS 1
Presentation of Financial Statements
|
Non-current Liabilities
with Covenants
|
1 January
2024
|
The effect of these new
and amended Standards and Interpretations which are in issue but
not yet mandatorily effective is not expected to be
material.
The directors are
evaluating the impact that these standards may have on the
financial statements of Company.
4
Critical
accounting estimates and judgments
In preparing the Condensed
Interim Financial Statements, the Directors have to make judgments
on how to apply the Company’s accounting policies and make
estimates about the future. Estimates and judgements are
continuously evaluated based on historical experiences and other
factors, including expectations of future events that are believed
to be reasonable under the circumstances. In the future, actual
experience may deviate from these estimates and
assumptions.
The key assumptions
concerning the future and other key sources of estimation
uncertainty at the reporting date that have a significant risk of
causing a material adjustment to the carrying amounts of assets and
liabilities within the next financial year, are described
below.
5
Employees and
directors’ remuneration
There were no employees of
the Company in the period under review, other than the three
directors. Directors’ remuneration for the period was as
follows:
|
Unaudited
|
Unaudited
|
Audited
|
|
31
October
2024
£
|
31
October
2023
£
|
30
April
2024
£
|
Director
fees
|
36,000
|
36,000
|
72,000
|
Employers
N.I
|
-
|
|
-
|
|
36,000
|
36,000
|
72,000
|
6
Earnings per
Ordinary Share
There were no potentially
dilutive instruments in issue at the period end.
|
Unaudited
|
Unaudited
|
Audited
|
|
31 October
2024
|
31 October
2023
|
30
April
2024
|
Basic and dilutive
earnings per Ordinary Share
|
|
|
|
Earnings attributable to
Shareholders
|
(81,148)
|
(86,476)
|
(292,060)
|
Weighted average number of
Ordinary Shares
|
23,902,500
|
17,867,876
|
21,135,548
|
Per share
amount-(pence)
|
(0.34)
|
(0.48)
|
(1.38)
|
There is no difference
between the diluted loss per share and the basic loss per share
presented. Share options and warrants could potentially dilute
basic earnings per share in the future but were not included in the
calculation of diluted earnings per share as they are anti-dilutive
for the period presented.
7
Investments
held at fair value through profit and loss
Current
|
£
|
Cost at 31 October
2023
|
219,949
|
|
|
Cost at 30 April
2024
|
219,949
|
|
|
Cost at 31 October
2024
|
219,949
|
|
|
Fair value loss at 31
October 2023
|
(42,103)
|
Fair value loss at 30
April 2024
|
(86,920)
|
Fair value loss at
31 October 2024
|
(16,027)
|
|
|
Fair value of Investment
at 31 October 2023
|
74,506
|
Fair value of Investment
at 30 April 2024
|
29,689
|
Fair value of
Investment at 31 October 2024
|
13,663
|
|
|
Non –
Current
|
|
|
|
Cost at 31 October
2023
|
-
|
Additions
|
250,000
|
Cost at 30 April
2024
|
250,000
|
|
|
Cost at 31 October
2024
|
250,000
|
|
|
Fair value loss at 31
October 2023
|
-
|
Fair value loss at 30
April 2024
|
-
|
Fair value loss at
31 October 2024
|
-
|
|
|
Fair value of Investment
at 31 October 2023
|
-
|
Fair value of Investment
at 30 April 2024
|
250,000
|
Fair value of
Investment at 31 October 2024
|
250,000
|
On 3 November 2021, the Company acquired an
investment in Blue Star Helium Limited. The
investment
totalled AUD $400,000 at AUD 5.6
cents per share and was part of a AUD $15 million fundraise. The
Company holds 7,142,858
shares in Blue Star Helium Limited representing 0.45% of the total
issued shares in that company.
The investment was
recognised as a financial asset held at fair value through profit
and loss. It is classified as a current asset as the Company views
this as an asset which is likely to be held for the short term
only.
During the year a fair
value loss was recognised in the income statement reflecting the
fall in value from
the last revaluation date
of AUD 0.8 cents per share to AUD
0.0375 cents per share at the date of
these accounts. The shares were initially purchased for AUD
5.6 cents per
share.
During the 2024 financial
year the Company subscribed for £250,000 of new ordinary shares in
Trackimo to fulfil certain banking covenants and support Trackimo's
working capital leading up to a potential AIM IPO. Whilst the
shares were issued in July 2024, the
terms of the agreement were irrevocable and as such the investment
is treated as an equity investment at year end.
At 30 April 2024 a third party valuation reporting
indicating the fair value of the investment to be significantly
higher than the current carrying value. The valuation was based on
a discounted cash flow forecast (DCF) and included various
observable inputs. However, due to the inherent unpredictability of
future cash-flows and a lack of liquidity in a private company's
securities, the asset was not valued upwards at the end of the
period. The Company reviewed the valuation as at 31 October 2024 and noted there has been no
material change to the assumptions used in the valuation. As a
result there has been no adjustment to the carrying value of the
asset.
Accounting standards,
including IFRS 13, prescribe a three-level hierarchy for fair
valuing financial
instruments. The
investment in Blue Star Helium Limited has been measured and
recognised in the financial statements at Level 1 as the entity is
publicly quoted whilst the investment in Trackimo is considered
level 3. The three levels are described below:
Level
1: The fair value of
financial instruments traded in active markets (such as publicly
traded derivatives, and equity securities) is based on quoted
market prices at the end of the reporting year. The quoted market
price used for financial assets held by the Company is the current
bid price. These instruments are included in level
1.
Level
2: The fair value of
financial instruments that are not traded in an active market (e.g.
over-the counter derivatives) is determined using valuation
techniques that maximise the use of observable market data and rely
as little as possible on entity-specific estimates. If all
significant inputs required to fair value an instrument are
observable, the instrument is included in level
2.
Level
3: If one or more of the
significant inputs is not based on observable market data, the
instrument is included in level 3. This is the case for unlisted
equity securities.
8
Share Capital
& Share Premium
|
Ordinary
Shares
|
Share Capital
|
Share
Premium
|
Total
|
|
#
|
£
|
£
|
£
|
At 31 October
2023
|
23,902,500
|
239,025
|
1,004,380
|
1,243,405
|
At 30 April
2024
|
23,902,500
|
239,025
|
1,004,380
|
1,243,405
|
Movement for the
period
|
-
|
-
|
-
|
-
|
At 31 October
2024
|
23,902,500
|
239,025
|
1,004,380
|
1,243,405
|
9
Related Party
Transactions
Provision of
services:
Charlie Wood, a partner of Orana Corporate LLP,
is also a director of the Company. As a result, Orana Corporate LLP
is considered a related party under the applicable reporting
framework due to the common directorship and influence Charlie Wood has over both
entities.
Orana Corporate LLP has a
service agreement with the Company for the provision of accounting,
Company
secretarial and corporate
finance services. In the period Orana Corporate LLP accrued £12,000
(2023: £12,150) for these services from the
Company.
Directors'
remuneration:
For details of the
directors' remuneration paid in the year, refer to the Directors'
report.
As at 31 October 2024 the Directors were owed the
following amounts: Fungai Ndoro
£53,000 (2024: £41,000), Neil Ritson
£53,000 (2024: £41,000) and Charlie
Wood £46,700 (2024: £34,700).
Other than these there
were no other related party transactions.
10
Ultimate
Controlling Party
As at 31 October 2024, there was no ultimate
controlling party of the Company.
11
Post Balance
Sheet Events
There have been no other
material events subsequent to period end.
12
Nature of the
Interim Financial Statements
The Company Financial
Information presented above does not constitute statutory accounts
for the period under
review.
13
Approval of
the Condensed Interim Financial Statements
The Condensed Interim
Financial Statements were approved by the Board of Directors on
30 January 2025.